CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of CCI-779 in treating patients who have recurrent
glioblastoma multiforme. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.